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Laryngeal squamous cell carcinoma is very often diagnosed at advanced stages. The time interval 
between the specialist consultation and the start of treatment may contribute to better outcomes. 
Aim: the interval assessment between the first specialist evaluation and the treatment of patients 
with laryngeal squamous cell carcinoma. 
Study Design: longitudinal historical cohort. 
Materials and Methods: 272 consecutive patients with laryngeal squamous cell carcinoma seen 
between January, 1996 and December of 2004. Clinical and epidemiological data were evaluated, 
as well as their association with the time interval between the first specialist visit and the start of 
treatment. 
Result: the median time between first evaluation and treatment was 49 days. There was no relationship 
with gender, age, birth place, disease stage or education. 
Conclusion: the treatment median delay was 49 days, similar to what has been reported in other 
studies. 
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INTRODUCTION
Laryngeal cancer represents 2% of the cancer cases 
in Brazil, with estimates of 9,320 new cases in the year of 
2009, according to the National Cancer Institute -INCA1.
Epidermoid carcinoma is the most common his-
tological type and, despite the early symptoms, it is still 
frequently diagnosed in an advanced stage. Diagnosis and 
treatment delays can be broken down in two stages. The 
first stage, until it reaches specialized care, was influenced 
both by the patient who denied symptoms as well as delay 
in primary care. Another stage is diagnosis and treatment 
themselves. Although the time spent in the first stage is 
usually longer, being responsible for the advanced stage 
of the disease, delays in starting treatment may also bring 
about a worse outcome2,3. The present investigation aims at 
checking the time taken after the patient sees the specialist 
all the way to treatment onset, as well as its relationship 
with some clinical and epidemiological characteristics of 
the patients seen in a reference public medical care facility.
MATERIALS AND METHODS
This study is a series of retrospective cases, invol-
ving the review of the medical charts from 272 patients 
with laryngeal epidermoid carcinoma, consecutively seen 
between January of 1996 and December of 2004. We asses-
sed the time interval between the first patient visit to the 
head and neck surgery department and surgical treatment 
or radiotherapy onset, as well as its association with clini-
cal and epidemiological characteristics, including staging, 
gender, age, education and place of birth. Moreover, we 
also assessed treatment delays at different times (three 
years). The continuous quantitative variable (time) did not 
have a normal distribution, confirmed by the Kolmogorof-
Smirnoff test; thus, we employed the Mann-Whitney and 
Kruskal-Wallis non-parametric tests, considering significant 
those differences with p<0.05. The time intervals were 
expressed in medians, quartiles and percentiles. This study 
was approved by the Ethics in Research Committee of the 
institution - record # 659.
RESULTS
Patients averaged 58 years of age (36 to 83 years), 
237 males and 35 females. The complaint time averaged 
6 months. Forty-seven percent had been born in the state 
of São Paulo, 70% were illiterate or had not even finished 
junior high school; and 63% had advanced primary tumor 
(T3 or T4). As far as treatment is concerned, 132 were 
submitted to surgery and 85 to radiotherapy. Fifty-five 
patients were not followed up, and 19 were not treated 
either with surgery or radiotherapy because of not being 
clinically fit, they refused to do it or died. Twenty-seven 
patients did not return for treatment, six others were re-
ferred to radiotherapy and did not return for scheduled 
follow up and three patients chose to undergo treatment 
in another institution.
Among the 217 treated patients, the time interval 
between the first medical visit and treatment onset varied 
from 1 to 347 days, with a median of 49 days. The radio-
therapy onset median time was 58 days, and for surgery it 
was 43 days (Figure 1). As far as place of birth is concer-
ned, those patients from São Paulo took 47 days to start 
treatment, and those from other states took 53 days (Figure 
2, p=0.49). Illiterate patients or those who did not finish 
junior high school or with more school years than that took 
51 days, while those who finished high school or higher 
education took a median of 46 days (Figure 3, p=0.33). As 
far as staging is concerned, patients with T1 or T2 tumors 
took 47 days, those with T3 or T4 tumors took a median of 
49 days to start treatment (Figure 4, p=0.28). In the three 
Figure 1. Time interval between the first medical visit and treatment 
onset according to treatment mode.
Figure 2. Time interval between the first medical visit and treatment 
onset according to patient place of birth.
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different three-year intervals analyzed, between 1996 and 
1998 the median was of 54 days; between 1999 and 2001 
it was of 42 days and between 2002 and 2004 it was of 52 
days (Figure 5, p=0.09). The male patients had median wai-
ting time of 48 days and the females had 53 days (p=0.29). 
As far as age is concerned, we also did not find differences 
in treatment waiting time (Figure 6, p=0.24).
Figure 3. Time interval between the first medical visit and treatment 
onset according to patient educational level.
Figure 4. Time interval between the first medical visit and treatment 
onset according to the T stage.
Figure 5. Time interval between the first medical visit and treatment 
onset in the different three-year periods.
Figure 6. Time interval between the first medical visit and treatment 
onset according to age.
DISCUSSION
The diagnosis of laryngeal malignant neoplasia is 
based on pathology tests. Since the biopsy of these lesions 
requires endoscopy or direct laryngoscopy, the ultimate 
diagnosis is usually done by the consultant. During the 
time period evaluated, almost all the biopsies were done 
through direct laryngoscopy under general anesthesia, 
which may have increased the pretreatment time. As far 
as radiotherapy goes, which we did not have available, 
the time to treatment also counts in the referral to another 
clinic, however with the patient properly staged and with 
histological diagnosis. This study did not aim at compa-
ring the time taken between the two treatment options, 
and rather to record the time-to-treatment interval for 
patients who came to a specialized clinic. According to 
Primdahl et al., currently more image studies are ordered 
and radiotherapy has a more complex planning, however 
they mention equipment availability (linear accelerator) 
as a preponderant factor in the greater delay seen upon 
treatment onset, which in Denmark increased from 50 
to 70 days between 1992 and 20022. These authors esti-
mated that the increase of 20 days could reduce control 
rates in 10%2. Brouha et al. reported a median interval of 
49 days between the first consultation in one specialized 
clinic in Holland and treatment onset, and such interval 
was greater in laryngeal tumors4. Undoubtedly, treatment 
waiting depends on the availability of human and material 
703
Brazilian Journal of otorhinolaryngology 76 (6) novemBer/DecemBer 2010
http://www.bjorl.org  /  e-mail: revista@aborlccf.org.br
resources - depending on the infrastructure of the surgical 
center or radiotherapy. In a general hospital, resources are 
usually limited, treatment priorities may also cause con-
flicts. In a system working at full capacity, mild seasonal 
variations in disease incidence or temporary equipment 
unavailability may intensely reflect on this time interval. 
Despite the growing service complexity, which today em-
bodies multidisciplinary teams and standardizes a greater 
number of complementary methods, many stages can be 
ran simultaneously, which enables patient preparation in 
a shorter time interval. Considering the constant pursue 
of treatment gains, one must appreciate the possibility of 
shortening treatment waiting time. This is a doable goal, 
which can be reached with the rational use of resources. 
Unfortunately, the delay in the pre-diagnostic phase can-
not be tackled by the medical team. Although the time of 
symptoms is usually longer than the delay in diagnosis 
and treatment, according to Allison et al., a delay of more 
than one month in primary care is associated with the 
advanced-stage disease, and we did not notice an asso-
ciation with the time of complaint4. Teppo et al. associate 
a diagnostic delay and not the time of complaint as spe-
cific determining factor on the specific-disease survival5. 
Other authors also suggest that the treatment delay may 
influence the prognosis of these patients, either directly 
or indirectly. Epidermoid carcinomas may have different 
tumor duplication times, but they invariably grow, and 
tumor enlargement has direct impact on tumor surgical or 
radiotherapy treatment. Tumor growth may require greater 
resection in a noble area, with its consequences in recons-
truction and morbidity, it may even become impossible 
to resect. Equally important, the radiotherapy control rate 
is associated with tumor volume. Kowalski and Carvalho 
noticed that the patients with increments in TNM staging 
before treatment had the worst result, when paired with pa-
tients who kept the initial staging6. Barton et al., evaluated 
initial laryngeal tumors and did not observe pre-treatment 
time influence on prognosis; nonetheless, the waiting time 
assessed between the biopsy and radiotherapy onset had a 
median time of only 24 days7. On the other hand, Jensen 
et al. reported a median increase of 46% in tumor volume 
in 62% of the patients awaiting treatment onset after the 
28 day median8. This latest study may have overestimated 
tumor growth by means of patient-selection, since only 
patients with image exams repeated at different dates prior 
to treatment were included.
Most patients had low education levels and advan-
ced disease. The results show that there was no treatment 
priority based on clinical or epidemiological characteristics. 
Surprisingly, treatment delay was similar to what had been 
reported by developed countries2,4. Approximately 10% of 
the patients did not return after the first visit, and because 
of that we do not know whether they refused treatment 
or if they were seen in another institution. The 49-day 
delay (median) for treatment onset is exaggerated, since 
half of the patients were treated after a time interval equal 
to or greater than this. Considering the possible tumor 
growth in this period, to reduce such time may impact 
prognosis similarly or even higher than that of the use of 
new technologies.
CONCLUSION
The time between initial care with the specialist and 
treatment onset had a median value of 49 days, similar to 
what has been reported in other studies, but higher that 
what is adequate for cancer treatment.
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